Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 1
1(20.0%)
5Total
N/A(4)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07456930Not Yet Recruiting

Real-World Evaluation of Compl-AI for Predicting Early Medication Dropout in Opioid Use Disorder Treatment

Role: lead

NCT03407378Phase 1Completed

A Study to Investigate a New Treatment in Patients With Parkinson's Disease

Role: lead

NCT03174145Not ApplicableCompleted

Validation Study to Investigate the Effect of a New Treatment in Patients With Osteoarthritic Pain

Role: lead

NCT02459197Not ApplicableCompleted

A Proof of Concept Study to Investigate the Effect of a New Treatment in Patient With Chronic Pain

Role: lead

NCT02774213Completed

A Study to Collect Data About Analgesia in Patients With Bone Metastasis

Role: lead

NCT02989792Not ApplicableCompleted

A Study to Investigate the Genetic Variation of Dopamine Pathway in Patients With Chronic Pain

Role: lead

NCT02301169Not ApplicableCompleted

A Study to Investigate the Effects of a New Treatment in Patients With Chronic Pain

Role: lead

All 7 trials loaded